65400 Federal Register / Vol. 88, No. 183 / Friday, September 22, 2023 / Notices 

Dated: September 18, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–20525 Filed 9–21–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Advancing 

Translational Sciences; Notice of 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Center for 

Advancing Translational Sciences 

Advisory Council. 

This will be a hybrid meeting held inperson and virtually and will be open to 

the public as indicated below. 

Individuals who plan to attend inperson or view the virtual meeting and 

need special assistance or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. The meeting 

can be accessed from the NIH Videocast 

at the following link: http://

videocast.nih.gov/. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Advancing Translational Sciences Advisory 

Council. 

Date: September 28, 2023. 

Closed: 11:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, Building 31, Room F/G, 9000 

Rockville Pike, Bethesda, MD 20892. 

Open: 1:00 p.m. to 6:00 p.m. 

Agenda: Report from the Center Director, 

ARPA–H Presentation, Program Updates (2), 

Clearance of Concepts (3). 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, Building 31, Room F/G, 9000 

Rockville Pike, Bethesda, MD 20892. 

Contact Person: Anna L. Ramsey-Ewing, 

Ph.D., Executive Secretary, National Center 

for Advancing Translational Sciences, 

National Institutes of Health, 1 Democracy 

Plaza, Room 1072, Bethesda, MD 20892, 301– 

435–0809, anna.ramseyewing@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice no later than 15 days after the 

meeting at NCATSCouncilInput@

mail.nih.gov. The statement should include 

the name, address, telephone number and 

when applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors attending a meeting on 

campus or at an off-campus federal facility 

will be asked to show one form of 

identification (for example, a governmentissued photo ID, driver’s license, or passport) 

and to state the purpose of their visit. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.350, B—Cooperative 

Agreements; 93.859, Biomedical Research 

and Research Training, National Institutes of 

Health, HHS) 

Dated: September 18, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–20532 Filed 9–21–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Biological Chemistry 

and Macromolecular Biophysics Integrated 

Review Group; Macromolecular Structure 

and Function C Study Section. 

Date: October 12–13, 2023. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: James W. Mack, Ph.D., 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4154, 

MSC 7806, Bethesda, MD 20892, (301) 435– 

2037, mackj2@csr.nih.gov. 

Name of Committee: Biology of 

Development and Aging Integrated Review 

Group; Mechanisms of Cancer Therapeutics 

A Study Section. 

Date: October 16–17, 2023. 

Time: 8:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Careen K. Tang-Toth, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6214, 

MSC 7804, Bethesda, MD 20892, (301) 435– 

3504, tothct@csr.nih.gov. 

Name of Committee: Brain Disorders and 

Clinical Neuroscience Integrated Review 

Group; Pathophysiology of Eye Disease—1 

Study Section Pathophysiology of Eye 

Disease—1 Study Section (PED1). 

Date: October 16–17, 2023. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Afia Sultana, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4189, 

Bethesda, MD 20892, (301) 827–7083, 

sultanaa@mail.nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group; 

Clinical Management in General Care 

Settings Study Section. 

Date: October 16–17, 2023. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Place Georgetown, 2121 M 

Street NW, Washington, DC 20037. 

Contact Person: Jessica Campbell 

Chambers, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Bethesda, MD 20892, (301) 496–5693, 

jessica.chambers@nih.gov. 

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group; Cell 

Signaling and Molecular Endocrinology 

Study Section. 

Date: October 16–17, 2023. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Latha Malaiyandi, Ph.D., 

Scientific Review Officer, Center for 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 183 / Friday, September 22, 2023 / Notices 65401 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 812Q, 

Bethesda, MD 20892, (301) 435–1999, 

malaiyandilm@csr.nih.gov. 

Name of Committee: Brain Disorders and 

Clinical Neuroscience Integrated Review 

Group; Brain Injury and Neurovascular 

Pathologies Study Section. 

Date: October 16–17, 2023. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Alexander Yakovlev, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5206, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1254, yakovleva@csr.nih.gov. 

Name of Committee: Oncology 1—Basic 

Translational Integrated Review Group; Gene 

Regulation in Cancer Study Section. 

Date: October 16–17, 2023. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Manzoor A. Zarger, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6208, 

MSC 7804, Bethesda, MD 20892, (301) 435– 

2477, zargerma@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: September 18, 2023. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2023–20524 Filed 9–21–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Cancer Institute 

Council of Research Advocates. 

The meeting will be a hybrid meeting 

held in-person and virtually and will be 

open to the public as indicated below, 

with attendance limited to space 

available. Individuals who plan to 

attend in-person or view the virtual 

meeting and need special assistance or 

other reasonable accommodations, 

should notify the Contact Person listed 

below in advance of the meeting. The 

meeting can be accessed from the NIH 

Videocast at the following link: http:// 

videocast.nih.gov. 

Name of Committee: National Cancer 

Institute Council of Research Advocates. 

Date: October 4, 2023. 

Time: 12:00 p.m. to 3:15 p.m. 

Agenda: Welcome and Chairwoman’s 

Remarks, NCI Director’s Update, NCI 

Updates, and Legislative Update. 

Place: Porter Neuroscience Research 

Center, National Institutes of Health, 

Building 35A, Room 610, 35 Convent Drive, 

Bethesda, MD 20892–2580 (Hybrid Meeting). 

Contact Person: Amy Williams, Acting 

Director, NCI Office of Advocacy Relations, 

National Cancer Institute, NIH, 31 Center 

Drive, Building 31, Room 10A28, Bethesda, 

MD 20892, (240) 781–3406, williaam@

mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors attending a meeting on 

campus or at an off-campus federal facility 

will be asked to show one form of 

identification (for example, a governmentissued photo ID, driver’s license, or passport) 

and to state the purpose of their visit. 

Information is also available on the 

Institute’s/Center’s home page: NCRA: http:// 

deainfo.nci.nih.gov/advisory/ncra/ncra.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: September 18, 2023. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–20526 Filed 9–21–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOUSING AND 

URBAN DEVELOPMENT 

[Docket No. FR–7076–N–16] 

60-Day Notice of Proposed Information 

Collection: Rental Assistance 

Demonstration (RAD) Application 

Forms; OMB Control No.: 2577–0278 

AGENCY: Office of the Assistant 

Secretary for Public and Indian 

Housing, PIH, HUD. 

ACTION: Notice. 

SUMMARY: HUD is seeking approval from 

the Office of Management and Budget 

(OMB) for the information collection 

described below. In accordance with the 

Paperwork Reduction Act, HUD is 

requesting comment from all interested 

parties on the proposed collection of 

information. The purpose of this notice 

is to allow for 60 days of public 

comment. 

DATES: Comments Due Date: November 

21, 2023. 

ADDRESSES: Interested persons are 

invited to submit comments regarding 

this proposal. Written comments and 

recommendations for the proposed 

information collection can be sent 

within 60 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 60-day Review—Open 

for Public Comments’’ or by using the 

search function. Interested persons are 

also invited to submit comments 

regarding this proposal by name and/or 

OMB Control Number and should be 

sent to: Colette Pollard for a copy of the 

proposed forms or other available 

information, Department of Housing and 

Urban Development, 451 7th Street SW, 

Room 8210, Washington, DC 20410– 

5000; telephone 202–402–5534 (this is 

not a toll-free number) or email: 

PaperworkReductionActOffice@

hud.gov. 

FOR FURTHER INFORMATION CONTACT: Leea 

Thornton, Office of Policy, Program and 

Legislative Initiatives, Department of 

Housing and Urban Development, 451 

7th Street SW, Washington, DC 20410; 

telephone (202–402–6455). This is not a 

toll-free number. HUD welcomes and is 

prepared to receive calls from 

individuals who are deaf or hard of 

hearing, as well as individuals with 

speech or communication disabilities. 

To learn more about how to make an 

accessible telephone call, please visit 

https://www.fcc.gov/consumers/guides/ 

telecommunications-relay-service-trs. 

Copies of available documents 

submitted to OMB may be obtained 

from Ms. Thornton. 


lotter on DSK11XQN23PROD with NOTICES1